glp-1 market size Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Market Overview: GLP-1 Agonists and

Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration

The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues.Background on Semaglutide and LiraglutideSemaglutide and liraglutide are medications b

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

But patients are at the heart of the GLP-1 trend, and the []

Over the past year, Ive seen a growing number of patients achieving remarkable weight-loss success with GLP-1 medications

Please confirm your status as a healthcare professional to access the content.